Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.20
Ask: 3.30
Change: -0.05 (-1.52%)
Spread: 0.10 (3.125%)
Open: 3.30
High: 3.30
Low: 3.25
Prev. Close: 3.30
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: IS Solutions, Netservices, Plant Health Care...

Mon, 14th Sep 2009 09:51

Higher revenues helped software services group IS Solutions post broadly unchanged profits in the six months to June 30.Pre-tax profits for the period totalled £184,000, compared with £189,000 the previous year, as revenues soared to £5.12m from £3.64m. During the year, the company completed the purchase of headquarters on Sunbury on Thames and invested in establishing a branch office in the Indian sub-continent.Business communications group Netservices expects to post an operating loss of about £200,000 for the year to August 31 due to time it will take to develop relationships with clients.Depressed agricultural markets resulted in widening losses at natural plant supplement supplier Plant Health Care (PHC). Revenue in the six months to June 30 fell to $5.5m from $7.8m over the same period the previous year and pre-tax losses grew to $3.9m from $3.3m. PHC said that it had received large orders from the seed giant Monsanto for its Harpin seed treatment.China Wonder reported a drop in half year profits despite a 21% rise in sales revenue and said it continues to actively seek expansion opportunities both in the People's Republic of China and the United Kingdom. Pre-tax profit fell to £220,053 in the six month ended 30 June from £253,546 last time. Sales revenue for the period was £2.11m when compared to the £1,743,863 of sales for the same period in 2008.Expansion into Brazil and Germany helped Publishing Technologies, which provides online systems and management software to academic publishers, narrow losses sharply in the six months to June 30. Pre-tax losses totalled £99,000 for the period, compared with £299,000 for the same period the previous year. Revenue climbed to £7.7m from £7.3m.Environmental Recycling cut net losses from £1.8m to £0.54m in the half-year to June, on sales up to £427,000 (£179,000). The increasing recycling agenda has led to a considerable number of enquiries and negotiations in respect of the application of the PIM Process in various sectors, it said. The one major difficulty that remains is the ongoing litigation with the group's former CEO in Kyrgyzstan, it added.Intelligent Environments has signed a three year rolling contract with Home Retail priced on IE's transactional revenue model. IE will deliver a comprehensive electronic card statement system for Argos and Homebase store card customers.Biotech ValiRx has created a new wholly owned trading subsidiary, ValiMedix, to distribute a range of new diagnostic screening products acquired from Pasante Healthcare. The new diagnostic screening products principally comprise the Self Check screening products which allow an individual to check for potential health problems at an early stage. International Brand Licensing slipped into losses in the half year to June, losing £170,000 against a profit of £248,000. IBL said the figures should be considered against the backdrop of a very depressed sporting goods industry and a big exceptional gain last time. Timestrip, which makes labels indicating how long containers for food have been unsealed, saw higher revenues and reduced losses in the six months to June 30.. Revenues in the six months to June 30 climbed to £386m from £268m as losses narrowed to £453m from £697m.The firm also reported positive feedback from NHS trials of its TimeStripPlus technology which is used to show if a temperature sensitive product such as a drug has been exposed to incorrect temperatures.Angel Mining lost £1.5m in the 12 months ended 28 February versus £4.2m in 2008 following the reversal of impairment provisions of £3.2m linked to exploration costs at Black Angel in Greenland.The company, formerly known as Angus & Ross, wants to get Nalunaq in the south of Greenland into production this year then try and get the Black Angel mine producing by the end of 2010.Titanium Resources tumbled on Monday as it said sales fell to $19.8m in the six months ended 30 June from $32.5m previously, although some of that was due to the sale of a Bauxite mine last year.The loss after tax narrowed to $4.95m from $20.2m a year earlier as the cost of sales fell by 52% to $20.7m. 'We believe the company is on track to achieve operating profitability for H2 2009,' said boss John Sisay.Superconductor energy technology firm Zenergy Power has reported a big drop in revenue for the first half of 2009 to €0.2m from €1m and an increase in losses to £5m from £2.6m before.But it says continuing growth in its order backlog, €2.3m at the end of June, will 'smooth' its revenue recognition over reporting periods. 'However, in the short-term we expect lumpiness to be a feature of our revenue generation and this is certainly the case with our 2009 reporting.'Mobile marketing and advertising group Velti grew pre-tax profit to €2.7m in the six months to 30 June, up from €1.6m in 2008 on revenue 36% higher to €21.7m.'During the remainder of 2009 we will continue to build up momentum and grow the Company in a sustainable way with a strong focus on cash flow,' said chief executive Alex Moukas.Online retailer of ethical fashion and lifestyle products Adili saw pre-tax losses widen in the year to 30 April 2009 from £1.59m to £1.90m on sales that rose from £0.35m to £0.55m. Sales for the first five months of the current financial year are up 29% on a year earlier.The first half of 2009 saw loss before tax widen at biopharmaceutical contract manufacturer Angel Biotechnology to £0.52m from £0.46m, but revenue improved to £0.6m from £0.48m. 'Due to the structure of contracts we currently have, revenue recognition is necessarily delayed resulting in lower figures for H1 [first half] 2009 than might have been expected with the value of business signed. This situation is expected to be rectified in H2 [second half] 2009 and into 2010 as the revenues from these projects are recognised,' the company said.Security and fire alarm firm Westminster Group has won a tolling 12-month contract to provide 24-hour bodyguard protection to a rich individual and his family in the Middle East. The contract is worth £0.54m.
More News
31 Mar 2023 16:39

TRADING UPDATES: FireAngel signs with British Gas; Shanta pours gold

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
1 Mar 2023 20:09

TRADING UPDATES: Ediston signs 10-year lease with Marks & Spencer

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
1 Mar 2023 14:26

ValiRx incorporates new wholly-owned lab subsidiary

(Sharecast News) - Life science company ValiRx announced the incorporation of a new wholly-owned subsidiary, Inaphaea BioLabs, on Wednesday.

Read more
3 Feb 2023 13:41

TRADING UPDATES: Somero revenue short of outlook; SigmaRoc optimistic

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
26 Jan 2023 15:44

UK shareholder meetings calendar - next 7 days

Friday 27 January 
Avon Protection PLCAGM
Henderson Far East Income LtdAGM
Ixico PLCAGM
NB Global Monthly Income Fund LtdEGM re proposed managed wind-down
On The Beach Group PLCAGM
Pathfinder Minerals PLCGM re capital raise
Serica Energy PLCGM re consideration shares approval
Treatt PLCAGM
Monday 30 January 
Bluebird Merchant Ventures LtdAGM
Contango Holdings PLCAGM
Hollywood Bowl Group PLCAGM
SkinBioTherapeutics PLCGM re annual report review
Starwood European Real Estate Finance LtdEGM re capital return 
Webis Holdings PLCAGM
Tuesday 31 January 
Hydrogen Future Industries PLCAGM
Mobile Streams PLCAGM
Residential Secure Income PLCAGM (TBC)
Star Phoenix Group LtdGM re removal and appointment of auditor
Team PLCAGM
Yamana Gold IncSGM re transaction with Agnico Eagle Mines Ltd and Pan American Silver Corp
Zamaz PLCAGM
Wednesday 1 February 
Baronsmead Second Venture Trust PLCAGM
Baronsmead Venture Trust PLCAGM
Capricorn Energy PLCGM re directors removal and appointment of new directors
Catalyst Media GroupAGM
Hyve Group PLCAGM
Imperial Brands PLCAGM
Premier Miton Group PLCAGM
Renew Holdings PLCAGM
Schroder Asia Pacific Fund PLCAGM
Thursday 2 February 
abrdn Equity Income Trust PLCAGM
Alteration Earth PLCAGM
Baillie Gifford European Growth Trust PLCAGM
JPMorgan Indian Investment Trust PLCAGM
Sage Group PLCAGM
Schroder European Real Estate Investment Trust PLCAGM
Tectonic Gold PLCAGM
ValiRx PLCGM re fundraising
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
17 Jan 2023 21:40

TRADING UPDATES: Future Metals in JV; Gunsynd sells stake in investee

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Jan 2023 13:31

IN BRIEF: ValiRx seeks up to GBP1.5 million for new research facility

ValiRx PLC - Hatfield Heath, England-based life sciences company focused on early-stage cancer therapeutics and women's health - Raises GBP1 million from placing of 9.1 million shares at 11 pence each. Also will raise up to GBP500,000 more from a broker offer to retail investors at the same price. Turner Pope Investments Ltd will run the broker offer. Every four shares in the placing and retail offer come with a warrant to buy another new share at 14p over the next three years. Calls February 2 general meeting to approve the fund raise. Currently has a GBP10.1 million market capitalisation.

Read more
6 Dec 2022 11:31

ValiRx shares fall on test extension, but optimistic of other assets

(Alliance News) - ValiRx PLC on Tuesday saw shares drop, after extending its evaluation agreement with Hokkaido University to conduct further experimental testing.

Read more
24 Oct 2022 12:47

ValiRx forms new majority-owned breast cancer subsidiary

(Sharecast News) - Women's health and cancer therapeutics company ValiRx announced the formation of a new partially-owned subsidiary, Cytolytix, on Monday, which had signed an intellectual property licence agreement with King's College London (KCL).

Read more
24 Oct 2022 10:05

ValiRx teams with King's College London for cancer project

(Alliance News) - ValiRx PLC on Monday said it is making progress on its goal to introduce new academic projects into its portfolio, after launching subsidiary company Cytolytix Ltd and signing a licence agreement with King's College London.

Read more
8 Sep 2022 11:47

IN BRIEF: ValiRx shares up on new interim chief scientific officer

ValiRx PLC - Nuneaton, England-based drug development company - Appoints Catherine Tralau-Stewart as interim chief scientific officer. Says she has experience working across leading pharmaceutical companies and academic groups. Tralau-Stewart will review new, incoming science; enhance the progress of existing projects; and influence the overall strategic scientific direction of the company, ValiRx adds. Chief Executive Suzy Dilly comments: "I'm looking forward to having another in-house scientist with whom to share ideas and to develop and deliver upon our strategic ambitions. Cathy's wealth of experience in exactly the areas in which we wish to progress, makes her an excellent choice for this role."

Read more
31 Aug 2022 13:51

EARNINGS UPDATES: Windward widens loss as operating expenses rise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
13 Jul 2022 14:44

IN BRIEF: ValiRx shares jump on breast cancer drug candidate progress

ValiRx PLC - Nuneaton, England-based drug development company - Completes the evaluation of the impact of a peptide drug candidate against triple negative breast cancer. Evaluation concludes there is "good evidence" of biological activity and a "strong" rationale for further development. Adds that the drug candidate was investigated over nine months. Tests also demonstrate promising data on ovarian cancer cells, in addition to the targeted breast cancer cells. As a result, ValiRx has notified the academic team and intellectual property & licensing team at King's College London that it wants to proceed to full in-licensing.

Read more
5 Jul 2022 15:51

IN BRIEF:ValiRx gains GBP1.0 million from Turner Pope broker option

ValiRx PLC - Nuneaton, England-based drug development company - Announces that the broker option granted to Turner Pope Investments Ltd has been fully subscribed and raises GBP1.0 million before expenses.

Read more
30 Jun 2022 17:31

TRADING UPDATES: M&C Saatchi expects to deliver on annual profit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.